Skip to main content

Terray Therapeutics

Monrovia, United States

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

$120.0M raised
Oct 2024
Series B

Top Investors

MadronaTwo Sigma VenturesXTX VenturesGoldcrest CapitalKdT Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Terray Therapeutics

How much funding has Terray Therapeutics raised?
Terray Therapeutics has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Who are Terray Therapeutics's investors?
Terray Therapeutics's investors include Madrona, Two Sigma Ventures, XTX Ventures, Goldcrest Capital, KdT Ventures.
Where is Terray Therapeutics headquartered?
Terray Therapeutics is headquartered in Monrovia, United States.
What does Terray Therapeutics do?
Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
What stage is Terray Therapeutics at?
Terray Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Terray Therapeutics — Funding & Investors." VCBacked, October 17, 2024, https://www.vcbacked.co/company/terray-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Terray Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/terray-therapeutics
Wikipedia (cite web)
{{cite web |title=Terray Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/terray-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .